- Home
- CBFV vs QNCX Comparison
CBFV vs QNCX Comparison
Compare CBFV & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | QNCX |
|---|---|---|
| Founded | 1901 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.9M | 167.0M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CBFV | QNCX |
|---|---|---|
| Price | $33.70 | $0.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $38.00 | $10.00 |
| AVG Volume (30 Days) | 3.3K | ★ 134.5M |
| Earning Date | 04-28-2026 | 05-19-2026 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $43,557,000.00 | N/A |
| Revenue This Year | $12.14 | N/A |
| Revenue Next Year | $14.00 | N/A |
| P/E Ratio | $1,137.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.03 | $0.09 |
| 52 Week High | $37.75 | $4.55 |
Technical Indicators
Market Signals| Indicator | CBFV | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 27.61 |
| Support Level | $32.03 | N/A |
| Resistance Level | $34.09 | $0.98 |
| Average True Range (ATR) | 0.65 | 0.02 |
| MACD | -0.15 | 0.10 |
| Stochastic Oscillator | 8.56 | 12.53 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.